Novo Integrated Sciences Inc

General ticker "NVOS" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $820.3K

Novo Integrated Sciences Inc does not follow the US Stock Market performance with the rate: -35.4%.

Estimated limits based on current volatility of 12.9%: low 0.03$, high 0.04$

Factors to consider:

  • Current price 96.6% below estimated low
  • Earnings for 15 months up through Q1 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-08-31 to 2025-08-30

  • 2023-08-31 to 2024-08-30 estimated range: [1.08$, 3.49$]
  • 2024-08-30 to 2025-08-30 estimated range: [1.16$, 3.52$]

Financial Metrics affecting the NVOS estimates:

  • Negative: Non-GAAP EPS, $ of -0.66 <= 0.10
  • Negative: Operating profit margin, % of -40.49 <= 1.03
  • Negative: Operating cash flow per share per price, % of -14.96 <= 2.35
  • Negative: negative Net income
  • Positive: 1.31 < Industry earnings per price (median), % of 1.35

Similar symbols

Short-term NVOS quotes

Long-term NVOS plot with estimates

Financial data

YTD 2022-08-31 2023-08-31 2024-08-31
Operating Revenue $11.74MM $12.57MM $13.29MM
Operating Expenses $36.76MM $21.13MM $23.37MM
Operating Income $-25.03MM $-8.55MM $-10.08MM
Non-Operating Income $-8.04MM $-4.72MM $-6.05MM
Interest Expense $7.57MM $5.12MM $0.65MM
Income(Loss) $-33.07MM $-13.27MM $-16.13MM
Taxes $-0.02MM $0.00MM $0.00MM
Profit(Loss) $-33.05MM $-13.27MM $-16.13MM
Stockholders Equity $22.31MM $24.82MM $14.89MM
Assets $40.87MM $35.56MM $32.14MM
Operating Cash Flow $-5.88MM $-2.24MM $-2.24MM
Capital expenditure $0.19MM $0.05MM $0.05MM
Investing Cash Flow $0.16MM $-0.05MM $-0.05MM
Financing Cash Flow $-0.43MM $0.76MM $0.76MM
Earnings Per Share* $-11.28 $-1.30 $-0.89

* EPS are Split Adjusted, recent splits may be reflected with a delay.